Initiation of T-Helper cell immunity to Candida albicans by IL-12: The role of neutrophils

Chemical Immunology

Volumn 68, Issue , 1997, Pages 110-135

  Romani, Luigina ^a,b   Bistoni, Francesco ^a,b   Puccetti, Paolo ^a,c  

^a Depts Exp Med and Biochem Sci   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12;

CANDIDA ALBICANS; CELLULAR IMMUNITY; HELPER CELL; HUMAN; IMMUNOREGULATION; INFECTION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW;

EID: 0030924023     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058688     Document Type: Review

References (128)

1. Murphy JW, Friedman H, Bendinelli M: Fungal Infections and Immune Responses. New York, Plenum Press, 1993.
2. Romani L, Howard DH: Mechanisms of resistance to fungal infections. Curr Opin Immunol 1995; 7:517-523.
3. Romani L, Cenci E, Mencacci A, Bistoni F, Puccetti P: T helper cell dichotomy to Candida albicans: Implications for pathology, therapy, and vaccine design. Immunol Res 1995;14:148-162.
4. Romani L, Puccetti P, Bistoni F: Biological role of Th cell subsets in candidiasis. Chem Immunol 1996;63:115-137.
5. Bistoni F, Cenci E, Mencacci A, Schiaffella E, Mosci P, Puccetti P, Romani L: Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J Infect Dis 1993;168:1449-1457.
6. Cenci E, Mencacci A, Spaccapelo R, Tonnetti L, Mosci P, Enssle K-H, Puccetti P, Romani L, Bistoni F: T helper cell type 1 (Th1)-and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995;171: 1279-1288.
7. Bistoni F, Verducci G, Perito S, Vecchiarelli A, Puccetti P, Marconi P, Cassone A: Immunomodulation by a low-virulence, agerminative variant of Candida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection. J Med Vet Mycol 1988;26:285-299.
8. Vecchiarelli A, Cenci E, Puliti M, Blasi E, Puccetti P, Cassone A, Bistoni F: Protective immunity induced by low-virulence Candida albicans: Cytokine production in the development of the anti-infectious state. Cell Immunol 1989;124:334-344.
9. Cenci E, Bartocci A, Puccetti P, Mocci S, Stanley ER, Bistoni F: Macrophage colony-stimulating factor in murine candidiasis: Serum and tissue levels during infection and protective effect of exogenous administration. Infect Immun 1991;59:868-872.
10. Romani L, Mencacci A, Cenci E, Mosci P, Vitellozzi G, Grohmann U, Puccetti P, Bistoni F: Course of primary candidiasis in T-cell depleted mice infected with attenuated variant cells. J Infect Dis 1992;166:1384-1392.
11. + subset expression in murine candidiasis. Infect Immun 1992;60:4950-4952.
12. Romani L, Mencacci A, Grohmann U, Mocci S, Mosci P, Puccetti P, Bistoni F: Neutralizing antibody to interleukin-4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992;176:19-25.
13. Romani L, Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Tonnetti L, Grohmann U, Bistoni F: Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994;152:3514-3521.
14. Puccetti P, Mencacci A, Cenci E, Spaccapelo R, Mosci P, Enssle K-H, Romani L, Bistoni F: Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J Infect Dis 1994;169: 1325-1331.
15. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, Lazzaro D, Sellitto C, Scarpa S, Bellavia D, Lattanzio G, Bistoni F, Frati L, Cortese R, Gulino A, Ciliberto G, Costantini F, Poli V: Lymphoproliferative disorder and imbalanced T-helper response in C/EBPβ deficient mice. EMBO J 1995;14:1932-1941.
16. Spaccapelo R, Romani L, Tonnetti L, Cenci E, Mencacci A, Del Sero G, Tognellini R, Reed SG, Puccetti P, Bistoni F: TGF-β is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J Immunol 1995;155:1349-1360.
17. Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistoni F: Th1 and Th2 cytokine secretion patterns in murine candidiasis. Association of Th1 responses with acquired resistance. Infect Immun 1991;59:4647-4654.
18. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol 1993;150:925-931.
19. Romani L, Puccetti P, Mencacci A, Spaccapelo R, Cenci E, Tonnetti L, Bistoni F: Tolerance to staphylococcal enterotoxin B initiates Th1 cell differentiation in mice infected with Candida albicans. Infect Immun 1994;62:4047-4053.
20. Bistoni F, Vecchiarelli A, Cenci E, Puccetti P, Marconi P, Cassone A: Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect Immun 1986;51:668-674.
21. + lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect Immun 1989;57:3581-3587.
22. Cenci E, Romani L, Vecchiarelli A, Puccetti P, Bistoni F: T cell subsets and IFN-γ production in resistance to systemic candidosis in immunized mice. J Immunol 1990;144:4333-4339.
23. + lymphocytes with cytolytic activity. Eur J Immunol 1991;21:1567-1570.
24. Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P, Bistoni F: Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993;23:1034-1038.
25. Tonnetti L, Spaccapelo R, Cenci E, Mencacci A, Puccetti P, Coffman RL, Bistoni F, Romani L: Interleukin-4 and -10 exacerbate candidiasis in mice. Eur J Immunol 1995;25:1559-1565.
26. H2-like switch in candidiasis: New perspectives for therapy. Trends Microbiol 1995;3:237-240.
27. Mencacci A, Cenci E, Spaccapelo R, Tonnetti L, Romani L, Puccetti P, Bistoni F: Rationale for cytokine and anti-cytokine therapy of Candida albicans infection. J Mycol Méd 1995;5:25-30.
28. Romani L, Bistoni F, Mencacci A, Cenci E, Spaccapelo R, Puccetti P: IL12 in Candida albicans infections. Res Immunol 1995;146:532-538.
29. Ashman RB, Papadimitriou JM: Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 1995;59:646-672.
30. Savolainen J, Koivikko A, Kalimo K, Nieminen E, Viander M: IgE, IgA and IgG antibodies and delayed skin responses towards Candida albicans antigens in atopics with and without saprophytic growth. Clin Exp Allergy 1990;20:549-554.
31. Witkin SS, Jeremias J, Ledger WJ: Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis. J Med Vet Mycol 1989;27:57-58.
32. Regulez P, Garcia Fernandez JF, Moragues MD, Schneider J, Quindos G, Ponton J: Detection of anti-Candida albicans IgE antibodies in vaginal washes from patients with acute vulvovaginal candidiasis. Gynecol Obstet Invest 1994;37:110-114.
33. Savolainen J, Lammintausta K, Kalimo K, Viander M: Candida albicans and atopic dermatitis. Clin Exp Allergy 1993;23:332-339.
34. Back O, Scheynius A, Johansson SG: Ketoconazole in atopic dermatitis: Therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995;287:448-451.
35. Terada N, Konno A, Shirotory K, Fujisawa T, Atsuta J, Ichimi R, Kikuchi Y, Takaki S, Takatsu K, Togawa K: Mechanism of eosinophil infiltration in the patient with subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (Kimura's disease). Mechanism of eosinophil chemotaxis mediated by candida antigen and IL-5. Int Arch Allergy Immunol 1994;104:18-20.
36. Lilic D, Cant AJ, Abinun M, Calvert JE, Spickett GP: Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-γ) production. Clin Exp Immunol 1996;105:205-212.
37. Lilic D, Calvert JE, Cant AJ, Abinun M, Spickett GP: Chronic mucocutaneous candidiasis. II. Class and subclass of specific antibody responses in vitro and in vivo. Clin Exp Immunol 1996; 105:212-219.
38. Odds FC: Candida and Candidosis, ed 2. London, Baillière-Tindall, 1988.
39. + subset differentiation. Infect Agents Dis 1992;1:33-42.
40. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC III: Role of T-cell derived cytokines in the downregulation of immune response in parasitic and retroviral infection. Immunol Rev 1992;127:183-204.
41. Reed SG, Scott P: T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol 1993;5: 524-531.
42. Cutler JE: Putative virulence factors of Candida albicans. Annu Rev Microbiol 1991;45:187-218.
43. Hostetter MK: Adherence molecules in pathogenic fungi. Curr Opin Infect Dis 1996;9:141-145.
44. Coleman DC, Bennett DE, Sullivan DJ, Gallagher PJ, Henman MC, Shanley DB, Russell RJ: Oral Candida in HIV infection and AIDS: New perspectives/new approaches. Crit Rev Microbiol 1993; 19:61-82.
45. Fidel PL Jr, Sobel JD: The role of cell-mediated immunity in candidiasis. Trends Microbiol 1994; 2:202-206.
46. Francis P, Walsh TJ: Current approaches to the management of fungal infections in cancer patients: Part 1. Oncology 1992;6:81-92.
47. Pfaller MA: Epidemiology of candidiasis. J Hosp Infect 1995;30:329-338.
48. Brummer E, Morrison CJ, Stevens DA: Recombinant and natural gamma-interferon activation of macrophages in vitro: Different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect Immun 1985;49:724-730.
49. Marodi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB Jr: Enhancement of macrophage candidacidal activity by interferon-γ. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Ivest 1993;91:2596-2601.
50. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ: Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: Augmentation by granulocyte colony-stimulating factor and interferon-γ. J Infect Dis 1992;166:668-673.
51. Stevenhagen A, Van Furth R: Interferon-γ activates the oxidative killing of Candida albicans by human granulocytes. Clin Exp Immunol 1993;91:170-175.
52. Kullberg BJ, Van't Wout JW, Hoogstraten C, Van Furth R: Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 1993;168:436-443.
53. Ausiello CM, Urbani F, Gessani S, Spagnoli GC, Gomez M, Cassone A: Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans. Infect Immun 1993;61:4105-4111.
54. Jones-Carson J, Vazquez-Torres A, van der Heyde HC, Warner T, Wagner RD, Balish E: γ/δ T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat Med 1995;1:552-557.
55. Romagnani S: Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994:6:838-846.
56. Adorini L, Magram J, Trembeau S: The role of endogenous IL12 in the induction of Th1-cell-mediated autoimmune diseases. Res Immunol 1995;146:645-651.
57. Nelson RD, Shibata N, Podzorski RP, Herron MJ: Candida mannan: Chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin Microbiol Rev 1991;4:1-19.
58. + cells are genetically restricted effectors and their production requires CD4 and I-A expression. Int Arch Allergy Immunol 1996;109:334-343.
59. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM: Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody: Evidence for a T cell-dependent, interferon gammma-independent mechanism. J Exp Med 1990;171:115-127.
60. Powrie F, Menon S, Coffman RL: Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993;23:3043-3049.
61. Sher A, Coffman RL: Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu Rev Immunol 1992;10:385-409.
62. Kaufmann SHE, Reddehase MJ: Infection of phagocytic cells. Curr Opin Immunol 1989;2:43-49.
63. Stein M, Keshav S, Harris N, Gordon S: Interleukin-4 potently enhances murine macrophage mannose receptor receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med 1992;176:287-292.
64. Liew FY, Li Y, Severn A, Millot S, Schmidt J, Salter M, Moncada S: A possible novel pathway of regulation by murine Th2 cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur J Immunol 1991;21:2489-2494.
65. Fidel PL Jr, Lynch ME, Sobel JD: Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun 1993:61:1990-1995.
66. + lymphocytes in resistance to mucosal candidiasis. Infect Immun 1991;59:2447-2455.
67. Fidel PL Jr, Lynch ME, Sobel JD: Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun 1993;61:4202-4207.
68. Fidel PL Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R: Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis 1993;168:1458-1465.
69. Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Cenci E, Wolf S, Puccetti P, Bistoni F: Interleukin-12 but not interferon-γ production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur J Immunol 1994;24:909-915.
70. Romani L, Mencacci A, Tonnetti L, Spaccapelo R, Cenci E, Puccetti P, Wolf SF, Bistoni F: IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol 1994;152:5167-5175.
71. + T helper cell 1 development in interleukin-6-deficient mice infected with Candida albicans. J Exp Med 1996;183:1345-1355.
72. + subset differentiation in Candida albicans-infected mice. Infect Immun 1993:61:3769-3774.
73. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 1994;24:793-798.
74. + cells. Annu Rev Immunol 1994;12:635-673.
75. Bradley LM, Dalton DK, Croft M: A direct role for IFN-γ in regulation of Th1 cell development. J Immunol 1996;157:1350-1358.
76. Bianchi R, Grohmann U, Belladonna ML, Silla S, Fallarino F, Ayroldi E, Fioretti MC, Puccetti P: IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells. J Immunol 1996;157:1589-1597.
77. Trinchieri G, Scott P: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions. Res Immunol 1995;146:423-431.
78. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH: Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-358.
79. Imam N, Carpenter CJ, Mayor KH, Fisher A, Stein M, Dauforth SB: Hierarchical pattern of mucosal Candida infection in HIV-seropositive women. Am J Med 1990;89:142-146.
80. Smith PD, Eisner MS, Manischewitz JF, Gill VJ, Masur H, Fox CF: Esophageal disease in AIDS is associated with pathologic processes rather than mucosal human immunodeficiency virus type 1. J Infect Dis 1993;167:547-552.
81. Coogan MM, Sweet SP, Challacombe SJ: Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in immunodeficiency virus infection and AIDS. Infect Immun 1994;62:892-896.
82. Moore RD, Chaisson RE: Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996;124:633-642.
83. McCarthy GM: Host factors associated with HIV-related oral candidiasis. A review. Oral Surg Oral Med Oral Pathol 1992;73:181-186.
84. Cannon RD, Holmes AR, Mason AB, Monk BC: Oral Candida: Clearance, colonization, or candidiasis? J Dent Res 1995;74:1152-1161.
85. Clerici M, Shearer GM: A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
86. Romagnani S, Maggi E: Th1 versus Th2 responses in AIDS. Curr Opin Immunol 1994;4:616-622.
87. Mosmann T: Cytokine patterns during the progression to AIDS. Science 1994;265:193-194.
88. Graziosi C, Pantaleo G, Gantt KR, Fortin J-P, Demarest JF, Cohen OJ, Sékaly RP, Fauci AS: Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 1994;265:248-252.
89. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-1724.
90. De Bernardis F, Chiani P, Ciccozzi M, Pellegrini G, Ceddia T, D'Offizzi G, Quinti I, Sullivan PA, Cassone A: Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 1996;64:466-471.
91. Cassone A, Palma C, Djeu JY, Aiuti F, Quinti I: Anticandidal activity and interleukin-1β and interleukin-6 production by polymorphonuclear leukocytes are preserved in subjects with AIDS. J Clin Microbiol 1993;31:354-357.
92. Domer JE: Intragastric colonization of infant mice with Candida albicans induces systemic immunity demonstrable upon challenge as adults. J Infect Dis 1988;157:950-958.
93. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste-Amezaga M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1378-1398.
94. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-4027.
95. Ma X, D'Andrea A, Kubin M, Aste-Amezaga M, Sartori A, Monteiro J, Showe J, Wysocka M, Trinchieri G: Production of IL-12. Res Immunol 1995;146:432-438.
96. Cassatella MA, Meda L, Gasperini S, D'Andrea A, Ma X, Trinchieri G: Interleukin-12 production by human polymorphonuclear leukocytes. Eur J Immunol 1995;25:1-5.
97. Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-26.
98. Bodey GP, Anaissie EJ: Chronic systemic candidiasis. Eur J Clin Microbiol Infect Dis 1989;8: 855-857.
99. + T helper subset selection in mice with candidiasis. J Immunol 1997;158: 2356-2362.
100. Ramani L, Mencacci A, Cenci E, Spaccapelo R, Del Sero G, Nicoletti I, Trinchieri G, Bistoni F, Puccetti P: Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J Immunol 1997;158:5349-5356.
101. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuler G: Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper cells. Eur J Immunol 1996;26:659-668.
102. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin-10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-1048.
103. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin-12 cures mice infected with Leishmania major. J Exp Med 1993;177:1505-1509.
104. Sypek JP, Chung CL, Mayor SE, Subramanyan JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: Interleukin-12 initiates a protective T helper type 1 immune response. J Exp Med 1993;177:1797-1802.
105. Alfonso LC, Sharton TM, Vieira LQ, Wysocka M, Trincheiri G, Scott P: The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994;263:235-237.
106. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A, Interleukin-12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-6119.
107. Finkelman FD, Madden KB, Cheever AW, Katona IM, Morris SC, Gately MK, Hubbard BR, Gause WC, Urban JF Jr: Effects of interleukin-12 on immune response and host protection in mice infected with intestinal nematode parasites. J Exp Med 1994;179:1563-1572.
108. Wynn TA, Eltoum I, Oswald IP, Cheever AW, Sher A: Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 1994;179:1551-1561.
109. Tripp CS, Wolf SF, Unanue ER: Interleukin-12 and tumor necrosis factor α are costimulators of Interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90:3725-3729.
110. Sedegah M, Finkelman F, Hoffman SL: Interleukin-12 induction of interferon γ-dependent production against malaria. Proc Natl Acad Sci USA 1994;91:10700-10702.
111. Clemons KV, Brummer E, Stevens DA: Cytokine treatment of central nervous system infection: Efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 1994;38:460-464.
112. Gazzinelli RT, Giese NA, Morse HC III: In vivo treatment with interleukin-12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med 1994;180:2199-2208.
113. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor (interleukin-12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993;177:1199-1204.
114. Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, Findelman FD: Effects of IL-12 on in vivo cytokine expression and Ig isotype selection. J Immunol 1994;152: 1047-1056.
115. Wang ZE, Zheng S, Corry DB, Dalton DK, Seder RA, Reiner SL, Locksley RM: Interferon-γ-independent effects of interleukin-12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci USA 1994;91:12932-12936.
116. Finkelman FD, Madden KB, Cheever AW, Katona IM, Morris SC, Gately MK, Hubbard BR, Gause WC, Urban JF Jr: Effects of interleukin-12 on immune response and host protection in mice infected with intestinal nematode parasites. J Exp Med 1994;179:1563-1572.
117. Kawakami K, Tohyama M, Xie Q, Saito A: IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neofarmans. Clin Exp Immunol 1996;104:208-214.
118. Khoo SK, Denning DW: Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994;19(S1): 41-48.
119. Kurup VP, Seymour BWP, Choi H, Coffman RL: Particulate Aspergillus fumigatus antigens elicit a Th2 resposne in BALB/c mice. J Allergy Clin Immunol 1994;93:1013-1020.
120. Romani L, Puccetti P, Bistoni F: Interleukin-12 in infectious diseases. Clin Microbiol Rev, in press.
121. Wheat J: Histoplasmosis: Recognition and treatment. Clin Infect Dis 1994;19(S1):19-27.
122. Zhou P, Sieve MC, Bennett J, Kwon-Chung KJ, Tewari RP, Gazzinelli RT, Sher A, Seder RA: IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J Immunol 1995;155:785-795.
123. Magee DM, Cox RA: Roles of interferon gamma and interleukin-4 in genetically determined resistance to Coccidioides immitis. Infect Immun 1995;63:3514-3519.
124. Magee DM, Cox RA: Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect Immun 1996;64:3609-3613.
125. Hoashi M, Imayama S, Hori Y, Kashiwagi S: An AIDS patient with atopic dermatitis-like eruption responsive to systemic anti-fungal treatment. J Dermatol 1992;19:972-975.
126. Elmets CA: Management of common superficial fungal infections in patients with AIDS. J Am Acad Dermatol 1994;31:S60-S63.
127. Lacour M: Acute infections in atopic dermatitis: A clue for a pathogenic role of a Th1/Th2 imbalance? Dermatology 1994;188:255-257.
128. Walsh TJ, Heimenz J, Pizzo PA: Evolving risk factors for invasive fungal infections: All neutropenic patients are not the same. Clin Infect Dis 1994;18:793-798.